Amgen Drug for Lung Cancer Suspended After Deaths (Update3) - Bloomberg

Amgen Drug for Lung Cancer Suspended After Deaths (Update3) Bloomberg - 56 minutes ago Motesanib and the bone treatment denosumab are at the forefront of Amgen's efforts to become a major provider of cancer medicines. ...

Study Identifies Causes of Bone Loss in Breast Cancer Survivors - DG News

Study Identifies Causes of Bone Loss in Breast Cancer Survivors DG News - 1 hour ago Among 64 breast cancer patients referred to a bone health clinic, 78% had at least 1other cause of bone loss, including vitamin D deficiency, ... Causes Of Bone Loss In Breast Cancer Survivors Include Cancer ... Science Daily (press release) all 9 news articles

UPDATE 1-EU agency backs IDM Pharma's bone cancer drug; shrs up - Reuters UK

UPDATE 1-EU agency backs IDM Pharma's bone cancer drug; shrs up Reuters UK, UK - Nov 18, 2008 O: Quote, Profile, Research) said advisors to the European Commission recommended the approval of its experimental treatment for a rare bone cancer, ... IDM Pharma shares jump on cancer drug ruling CNNMoney.com IDM Pharma Gains on Drug's Positive European Review (Update3) Bloomberg Delayed quote data MarketWatch Zacks.com - Pharmacy Europe all 30 news articles

CTS: Proton Therapy Reduces Bone Marrow Toxicity in Lung Cancer ... - MedPage Today

CTS: Proton Therapy Reduces Bone Marrow Toxicity in Lung Cancer ... MedPage Today, NJ - Nov 18, 2008 18 -- Non-small-cell lung cancer patients on chemotherapy who undergo treatment with proton beam radiation appear to suffer less bone marrow toxicity than ...

Two-Time Cancer Survivor's Tale of Thanksgiving - MarketWatch

Two-Time Cancer Survivor's Tale of Thanksgiving MarketWatch - 1 hour ago They will also reconstruct the patient's thumbs using remnants of bone and skin from his chest and groin areas. The patient will be placed in a hyperbaric ...